Vanectyl-P 5 mg Tablet is a Health Canada–registered veterinary drug (DIN 00170925) held by Zoetis Canada Inc, containing Trimeprazine Tartrate. Health Canada lists its status as Marketed (status date 19 Feb 2016). Nexara Health has matched 22 registrations of Trimeprazine Tartrate across 5 other regulated markets.
Health Canada registration
| DIN | 00170925 |
|---|---|
| Brand name | Vanectyl-P |
| Active ingredient | Trimeprazine Tartrate |
| Strength | 5 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Zoetis Canada Inc |
| Status | Marketed — 19 Feb 2016 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Trimeprazine Tartrate registered in other markets
22 registrations of the same molecule in 5 national registries outside Canada (first 19 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| MA | Theralene | — | 2.5 MG | Sirop | P | CNOPS liste des medicaments |
| MA | Theralene Pec. Bb | — | 1.25 MG | Sirop | P | CNOPS liste des medicaments |
| South Africa | Vallergan Forte | Sanofi Aventis South Africa (Pty) Ltd | 30 mg/5ml | Syr | S5 | DoH SEP database |
| Taiwan | Trimeprazine Tartrate | Sifa Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Trimeprazine Tartrate Tablets "Honten" | 應元化學製藥股份有限公司 | 錠劑 | 已註銷 | TFDA | |
| United Kingdom | Alimemazine 1.5mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 10mg tablets | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 10mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 10mg/5ml oral solution sugar free | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 15mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 30mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 30mg/5ml oral solution sugar free | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Alimemazine 5mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United States | Trimeprazine Tartrate | Guangan Kingday Pharma & Chem Co., Ltd. | Powder | FDA NDC | ||
| United States | Trimeprazine Tartrate | Pcas France | Powder | FDA NDC | ||
| United States | Trimeprazine Tartrate | R.L.Fine Chem Private Limited | Powder | FDA NDC | ||
| United States | Trimeprazine Tartrate | Darmerica, LLC | Powder | FDA NDC | ||
| United States | Trimeprazine Tartrate | Professional Compounding Centers of America | Powder | FDA NDC | ||
| United States | Trimeprazine Tartrate | Wuhan Biocause Pharmaceutical Development Co., Ltd | Powder | FDA NDC |
See every manufacturer of Trimeprazine Tartrate worldwide →
Regulator price references for Trimeprazine Tartrate
Published list or reimbursement prices for Trimeprazine Tartrate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| MA | Theralene | 2.5mg | 1 FLACON 150 ML | 13.80 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Theralene Pec. Bb | 1.25mg | 1 FLACON 150 ML | 14.50 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| South Africa | Vallergan Forte | 30mg/5ml | 100 | 277.89 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Vanectyl-P (DIN 00170925) marketed in Canada?
Yes. Health Canada lists DIN 00170925 as Marketed as of 19 Feb 2016.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Trimeprazine Tartrate registered outside Canada?
Yes — Nexara Health has matched 22 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00170925, status date 2016-02-19; national medicine registries: CNOPS liste des medicaments, DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, DoH SEP database. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00170925, status date 2016-02-19; national medicine registries: CNOPS liste des medicaments, DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, DoH SEP database.
Health Canada Drug Product Database (DPD), DIN 00170925, status date 2016-02-19; national medicine registries: CNOPS liste des medicaments, DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, DoH SEP database. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.